DCM
STJ

Dupont Capital Management’s St Jude Medical STJ Stock Holding History

Dupont Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,800
Closed -$1.03M – 940
2016
Q4 		$1.03M Hold
12,800
– – 0.02% 484
2016
Q3 		$1.02M Hold
12,800
– – 0.02% 449
2016
Q2 		$998K Buy
+12,800
New +$913K 0.02% 448
2016
Q1 		– Sell
-56,210
Closed -$3.47M – 730
2015
Q4 		$3.47M Buy
56,210
+22,748
+68% +$1.43M 0.08% 227
2015
Q3 		$2.11M Buy
+33,462
New +$2.39M 0.05% 321
2014
Q1 		– Sell
-110,963
Closed -$6.87M – 674
2013
Q4 		$6.87M Sell
110,963
-132,928
-55% -$7.7M 0.12% 141
2013
Q3 		$13.1M Sell
243,891
-38,509
-14% -$1.98M 0.24% 87
2013
Q2 		$12.9M Buy
+282,400
New +$12.2M 0.24% 85

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Dupont Capital Management's STJ Position: Q1 2017 in Review

Dupont Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 12,800 shares — an estimated $1.03M sold.

Dupont Capital Management first reported a position in STJ in Q2 2013 and held it in 8 quarters. The position peaked at $13.1M in Q3 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Dupont Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Dupont Capital Management sold 12,800 St Jude Medical shares in Q1 2017, an estimated $1.03M.
  • Dupont Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 8 quarters.
  • Dupont Capital Management's St Jude Medical position peaked at $13.1M in Q3 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Dupont Capital Management's 13F filing for Q1 2017, filed 27 Apr 2017.